# Intermountain Medical Center

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/intermountain-medical-center/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 48.4 |
| Citations | 563,113 |
| City | Murray |
| Country | US |
| Description | Intermountain Medical Center is a research organisation in Murray, US. OpenAlex records 4,083 works and 563,113 citations for it. 992 researchers list it as their most recent affiliation. |
| Homepage | https://intermountainhealthcare.org/locations/intermountain-medical-center/hospital-information/ |
| OpenAlex ID | https://openalex.org/I2803061204 |
| Region | Utah |
| Researchers | 992 |
| ROR ID | https://ror.org/009c06z12 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q6047575 |
| Works | 4,083 |

## University papers

Showing 12 of 28.

- [Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020](https://scholariq.org/papers/symptom-duration-and-risk-factors-for-delayed-return-to-usual-health-among/)
- [Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients](https://scholariq.org/papers/early-remdesivir-to-prevent-progression-to-severe-covid-19-in-outpatients/)
- [Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease](https://scholariq.org/papers/continuous-intravenous-epoprostenol-for-pulmonary-hypertension-due-to-the/)
- [Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study](https://scholariq.org/papers/clinical-severity-of-and-effectiveness-of-mrna-vaccines-against-covid-19-from/)
- [Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity](https://scholariq.org/papers/association-between-mrna-vaccination-and-covid-19-hospitalization-and-disease/)
- [Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021](https://scholariq.org/papers/comparative-effectiveness-of-moderna-pfizer-biontech-and-janssen-johnson-and-amp/)
- [Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial](https://scholariq.org/papers/effect-of-icosapent-ethyl-on-progression-of-coronary-atherosclerosis-in-patients/)
- [Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19](https://scholariq.org/papers/effect-of-hydroxychloroquine-on-clinical-status-at-14-days-in-hospitalized/)
- [Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High-Risk Patients With Diabetes](https://scholariq.org/papers/effect-of-screening-for-coronary-artery-disease-using-ct-angiography-on/)
- [Short‐Term Exposure to Fine Particulate Matter Air Pollution Is Preferentially Associated With the Risk of ST‐Segment Elevation Acute Coronary Events](https://scholariq.org/papers/short-term-exposure-to-fine-particulate-matter-air-pollution-is-preferentially/)
- [Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System](https://scholariq.org/papers/impact-of-testosterone-replacement-therapy-on-myocardial-infarction-stroke-and/)
- [Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial](https://scholariq.org/papers/tixagevimab-cilgavimab-for-treatment-of-patients-hospitalised-with-covid-19-a/)

## University researchers

- [Viet T. Le](https://scholariq.org/researchers/viet-t-le/)
- [Mark Nguyen](https://scholariq.org/researchers/mark-nguyen/)

## University top topics

Showing 8 of 25.

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Sepsis Diagnosis and Treatment](https://scholariq.org/topics/sepsis-diagnosis-and-treatment/)
- [Intensive Care Unit Cognitive Disorders](https://scholariq.org/topics/intensive-care-unit-cognitive-disorders/)
- [Cardiac Arrhythmias and Treatments](https://scholariq.org/topics/cardiac-arrhythmias-and-treatments/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)
- [Mechanical Circulatory Support Devices](https://scholariq.org/topics/mechanical-circulatory-support-devices/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.